US Patent Issued to Precision for Medicine on Sept. 8 for "MYH11/NDE1 region as epigenetic marker for the identification of endothelial progenitor cells (EPCs)" (German Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,403, issued on Sept. 8, was assigned to Precision for Medicine GmbH (Berlin).

"MYH11/NDE1 region as epigenetic marker for the identification of endothelial progenitor cells (EPCs)" was invented by Sven Olek (Berlin) and Kati Bourquain (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method, in particular an in vitro method, for identifying endothelial progenitor cells (EPCs), comprising analyzing epigenetic modifications/properties of (including the methylation status) of at least one CpG position in the mammalian gene region for muscle myosin heavy chain 11 (MYH11) and nuclear distribution protein nudE homol...